Table 3.

Convergent validity of patient-assessed dyspnoea in the EVEREST trial at Day 1

Reference measure (Day 1)	Patient-assessed dyspnoea	P-value
Spearman's correlationa
Physician-assessed dyspnoea	0.289	<0.0001
Physician-assessed orthopnoea	0.214	<0.0001
Physician-assessed JVD	0.157	<0.0001
Physician-assessed oedema	0.155	<0.0001
Body weight	0.200	<0.0001
χ2 associationb NYHA class	198.17	<0.0001

^aSpearman's correlations between patient self-assessed dyspnoea and changes in physician-assessed signs/symptoms and body weight at Day 1 (all patients).

^bχ² test on association. For patient-assessed dyspnoea, improved = markedly/moderately better, unchanged = minimally better/no change/minimally worse, and worsened = moderately/markedly worse.